New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Glucagon-like peptide-1 receptor agonists (GLP-1RA) drugs like Ozempic and Wegovy are called “miracle drugs” by some pharmacists for their ability to help those with diabetes to lose weight. The drugs ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...